|
HY-100226-10mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-100226-5mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-100226-50mg
|
MedChemexpress LLC
|
A-205804 [CAS 251992-66-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-100596-10mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-100mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-200mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-5mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-50mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100596-500mg
|
MedChemexpress LLC
|
AS1842856 [CAS 836620-48-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101257-1mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101257-10mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101257-25mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101257-5mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101257B-10mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101257B-100mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101257B-25mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101257B-5mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101257B-50mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
|
HY-101454-10mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-100mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-25mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-5mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-50mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101872A-10mg
|
MedChemexpress LLC
|
GSK-872 (hydrochloride) [CAS 2703752-81-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-101872A-100mg
|
MedChemexpress LLC
|
GSK-872 (hydrochloride) [CAS 2703752-81-0]
|
|
COVID-19-immunoregulation
|
|
